Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,115 | 2,175 | 30.04. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | NANOFORM: Disclosure of Major Holdings under Law 163/2024 | 1 | Cision News | ||
25.04. | New shares of Nanoform registered with the trade register | 1 | Cision News | ||
24.04. | Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines | 1 | Cision News | ||
24.04. | Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines | 4 | Cision News | ||
16.04. | Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024 | 2 | Cision News | ||
16.04. | Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc | 1 | Cision News | ||
09.04. | Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer | 347 | PR Newswire | Nanoform Finland Plc
April 9, 2024
09.00 EEST / 08.00 CEST
HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company... ► Artikel lesen | |
26.03. | The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals | 1 | Cision News | ||
12.03. | Notice to the Annual General Meeting of NANOFORM FINLAND Plc | 1 | Cision News | ||
12.03. | Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 and 1/2020 | 1 | Cision News | ||
06.03. | Nanoform Finland Plc - Manager's transactions - Jeanne Thoma | 1 | Cision News | ||
06.03. | Nanoform Finland Plc - Manager's transactions - Albert Hæggström | 2 | Cision News | ||
06.03. | Nanoform Finland Plc - Manager's transactions - Miguel Calado | 2 | Cision News | ||
06.03. | Nanoform Finland Plc - Manager's transactions - Mads Laustsen | 1 | Cision News | ||
29.02. | NANOFORM: Strong momentum in Project Nanoenzalutamide | 1 | Cision News | ||
16.02. | Invitation to Nanoform's Q4 and FY 2023 Report Presentation | 1 | Cision News | ||
15.02. | Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines | 564 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen | |
26.01. | Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide | 630 | PR Newswire | THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF... ► Artikel lesen | |
10.01. | Nanoform Finland Plc - Manager's transactions - Albert Hæggström | 1 | Cision News | ||
10.01. | The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees | 2 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 40,950 | -1,56 % | EQS-DD: Formycon AG: Dr. Stefan Glombitza, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
24.04.2024 / 12:27... ► Artikel lesen |